185 related articles for article (PubMed ID: 19016711)
1. Topical treatment with CYP26 inhibitor talarozole (R115866) dose dependently alters the expression of retinoid-regulated genes in normal human epidermis.
Pavez Loriè E; Cools M; Borgers M; Wouters L; Shroot B; Hagforsen E; Törmä H; Vahlquist A
Br J Dermatol; 2009 Jan; 160(1):26-36. PubMed ID: 19016711
[TBL] [Abstract][Full Text] [Related]
2. Both all-trans retinoic acid and cytochrome P450 (CYP26) inhibitors affect the expression of vitamin A metabolizing enzymes and retinoid biomarkers in organotypic epidermis.
Pavez Loriè E; Chamcheu JC; Vahlquist A; Törmä H
Arch Dermatol Res; 2009 Aug; 301(7):475-85. PubMed ID: 19294396
[TBL] [Abstract][Full Text] [Related]
3. The involvement of cytochrome p450 (CYP) 26 in the retinoic acid metabolism of human epidermal keratinocytes.
Pavez Loriè E; Li H; Vahlquist A; Törmä H
Biochim Biophys Acta; 2009 Mar; 1791(3):220-8. PubMed ID: 19171200
[TBL] [Abstract][Full Text] [Related]
4. CYP26 inhibitor R115866 increases retinoid signaling in intimal smooth muscle cells.
Ocaya P; Gidlöf AC; Olofsson PS; Törmä H; Sirsjö A
Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1542-8. PubMed ID: 17510468
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the
Stevison F; Hogarth C; Tripathy S; Kent T; Isoherranen N
Drug Metab Dispos; 2017 Jul; 45(7):846-854. PubMed ID: 28446509
[No Abstract] [Full Text] [Related]
6. R115866 inhibits all-trans-retinoic acid metabolism and exerts retinoidal effects in rodents.
Stoppie P; Borgers M; Borghgraef P; Dillen L; Goossens J; Sanz G; Szel H; Van Hove C; Van Nyen G; Nobels G; Vanden Bossche H; Venet M; Willemsens G; Van Wauwe J
J Pharmacol Exp Ther; 2000 Apr; 293(1):304-12. PubMed ID: 10734183
[TBL] [Abstract][Full Text] [Related]
7. Expression of retinoid-regulated genes in lamellar ichthyosis vs. healthy control epidermis: changes after oral treatment with liarozole.
Pavez Loriè E; Gånemo A; Borgers M; Wouters L; Blockhuys S; van de Plassche L; Törmä H; Vahlquist A
Acta Derm Venereol; 2009; 89(1):12-20. PubMed ID: 19197536
[TBL] [Abstract][Full Text] [Related]
8. CYP26B1 plays a major role in the regulation of all-trans-retinoic acid metabolism and signaling in human aortic smooth muscle cells.
Ocaya PA; Elmabsout AA; Olofsson PS; Törmä H; Gidlöf AC; Sirsjö A
J Vasc Res; 2011; 48(1):23-30. PubMed ID: 20606468
[TBL] [Abstract][Full Text] [Related]
9. The CYP26 inhibitor R115866 potentiates the effects of all-trans retinoic acid on cultured human epidermal keratinocytes.
Giltaire S; Herphelin F; Frankart A; Hérin M; Stoppie P; Poumay Y
Br J Dermatol; 2009 Mar; 160(3):505-13. PubMed ID: 19120344
[TBL] [Abstract][Full Text] [Related]
10. Local skin pharmacokinetics of talarozole, a new retinoic acid metabolism-blocking agent.
Baert B; De Spiegeleer B
Skin Pharmacol Physiol; 2011; 24(3):151-9. PubMed ID: 21228620
[TBL] [Abstract][Full Text] [Related]
11. Keratin 4 upregulation by retinoic acid in vivo: a sensitive marker for retinoid bioactivity in human epidermis.
Virtanen M; Törmä H; Vahlquist A
J Invest Dermatol; 2000 Mar; 114(3):487-93. PubMed ID: 10692107
[TBL] [Abstract][Full Text] [Related]
12. CYP26A1-specific antagonist influence on embryonic implantation, gene expression and endogenous retinoid concentration in rats.
Fritzsche B; Schuchardt JP; Schmidt A; Nau H; Schweigert FJ; Rühl R
Reprod Toxicol; 2010 Nov; 30(3):446-51. PubMed ID: 20580668
[TBL] [Abstract][Full Text] [Related]
13. Molecular and metabolic retinoid pathways in the human ocular surface.
Nezzar H; Chiambaretta F; Marceau G; Blanchon L; Faye B; Dechelotte P; Rigal D; Sapin V
Mol Vis; 2007 Sep; 13():1641-50. PubMed ID: 17893666
[TBL] [Abstract][Full Text] [Related]
14. Decreased retinoid concentration and retinoid signalling pathways in human atopic dermatitis.
Mihály J; Gamlieli A; Worm M; Rühl R
Exp Dermatol; 2011 Apr; 20(4):326-30. PubMed ID: 21410762
[TBL] [Abstract][Full Text] [Related]
15. Characterization of CYP26B1-Selective Inhibitor, DX314, as a Potential Therapeutic for Keratinization Disorders.
Veit JGS; De Glas V; Balau B; Liu H; Bourlond F; Paller AS; Poumay Y; Diaz P
J Invest Dermatol; 2021 Jan; 141(1):72-83.e6. PubMed ID: 32505549
[TBL] [Abstract][Full Text] [Related]
16. Keratins 2 and 4/13 in reconstituted human skin are reciprocally regulated by retinoids binding to nuclear receptor RARalpha.
Virtanen M; Sirsjö A; Vahlquist A; Törmä H
Exp Dermatol; 2010 Jul; 19(7):674-81. PubMed ID: 20456496
[TBL] [Abstract][Full Text] [Related]
17. Lipopolysaccharide opposes the induction of CYP26A1 and CYP26B1 gene expression by retinoic acid in the rat liver in vivo.
Zolfaghari R; Cifelli CJ; Lieu SO; Chen Q; Li NQ; Ross AC
Am J Physiol Gastrointest Liver Physiol; 2007 Apr; 292(4):G1029-36. PubMed ID: 17185629
[TBL] [Abstract][Full Text] [Related]
18. Climbazole boosts activity of retinoids in skin.
Adamus J; Feng L; Hawkins S; Kalleberg K; Lee JM
Int J Cosmet Sci; 2017 Aug; 39(4):411-418. PubMed ID: 28103388
[TBL] [Abstract][Full Text] [Related]
19. Retinoids and retinoid-metabolic gene expression in mouse adipose tissues.
Sima A; Manolescu DC; Bhat P
Biochem Cell Biol; 2011 Dec; 89(6):578-84. PubMed ID: 22077479
[TBL] [Abstract][Full Text] [Related]
20. Regulation of retinoid-mediated signaling involved in skin homeostasis by RAR and RXR agonists/antagonists in mouse skin.
Gericke J; Ittensohn J; Mihály J; Alvarez S; Alvarez R; Töröcsik D; de Lera AR; Rühl R
PLoS One; 2013; 8(4):e62643. PubMed ID: 23638129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
